406 related articles for article (PubMed ID: 22552606)
1. Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.
Zhao G; Qin Q; Zhang J; Liu Y; Deng S; Liu L; Wang B; Tian K; Wang C
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S301-11. PubMed ID: 22552606
[TBL] [Abstract][Full Text] [Related]
2. Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma.
Wu W; Zhang L; Lin J; Huang H; Shi B; Lin X; Huang Z; Wang C; Qiu J; Wei X
Oncotarget; 2016 Dec; 7(51):84416-84427. PubMed ID: 27793057
[TBL] [Abstract][Full Text] [Related]
3. Aberrant methylation of RASSF2A in human pancreatic ductal adenocarcinoma and its relation to clinicopathologic features.
Zhao L; Cui Q; Lu Z; Chen J
Pancreas; 2012 Mar; 41(2):206-11. PubMed ID: 21792082
[TBL] [Abstract][Full Text] [Related]
4. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin-1 regulates acinar-to-ductal metaplasia and supports cancer cell viability in pancreatic cancer.
Wauters E; Sanchez-Arévalo Lobo VJ; Pinho AV; Mawson A; Herranz D; Wu J; Cowley MJ; Colvin EK; Njicop EN; Sutherland RL; Liu T; Serrano M; Bouwens L; Real FX; Biankin AV; Rooman I
Cancer Res; 2013 Apr; 73(7):2357-67. PubMed ID: 23370328
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.
Chen WY; Wang DH; Yen RC; Luo J; Gu W; Baylin SB
Cell; 2005 Nov; 123(3):437-48. PubMed ID: 16269335
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
8. Involvement of annexin A8 in the properties of pancreatic cancer.
Hata H; Tatemichi M; Nakadate T
Mol Carcinog; 2014 Mar; 53(3):181-91. PubMed ID: 23001853
[TBL] [Abstract][Full Text] [Related]
9. Silencing of the hypoxia-inducible cell death protein BNIP3 in pancreatic cancer.
Okami J; Simeone DM; Logsdon CD
Cancer Res; 2004 Aug; 64(15):5338-46. PubMed ID: 15289340
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells.
Zhao G; Cui J; Zhang JG; Qin Q; Chen Q; Yin T; Deng SC; Liu Y; Liu L; Wang B; Tian K; Wang GB; Wang CY
Gene Ther; 2011 Sep; 18(9):920-8. PubMed ID: 21677689
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
12. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
13. Correlation between ECT2 gene expression and methylation change of ECT2 promoter region in pancreatic cancer.
Zhang ML; Lu S; Zhou L; Zheng SS
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):533-8. PubMed ID: 18842503
[TBL] [Abstract][Full Text] [Related]
14. Effects of bone sialoprotein on pancreatic cancer cell growth, invasion and metastasis.
Kayed H; Kleeff J; Keleg S; Felix K; Giese T; Berger MR; Büchler MW; Friess H
Cancer Lett; 2007 Jan; 245(1-2):171-83. PubMed ID: 16488077
[TBL] [Abstract][Full Text] [Related]
15. HIC1 attenuates invasion and metastasis by inhibiting the IL-6/STAT3 signalling pathway in human pancreatic cancer.
Hu B; Zhang K; Li S; Li H; Yan Z; Huang L; Wu J; Han X; Jiang W; Mulatibieke T; Zheng L; Wan R; Wang X; Hu G
Cancer Lett; 2016 Jul; 376(2):387-98. PubMed ID: 27085461
[TBL] [Abstract][Full Text] [Related]
16. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression and promoter methylation of the menin tumor suppressor in pancreatic ductal adenocarcinoma.
Cavallari I; Silic-Benussi M; Rende F; Martines A; Fogar P; Basso D; Vella MD; Pedrazzoli S; Herman JG; Chieco-Bianchi L; Esposito G; Ciminale V; D'Agostino DM
Genes Chromosomes Cancer; 2009 May; 48(5):383-96. PubMed ID: 19170121
[TBL] [Abstract][Full Text] [Related]
18. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
[TBL] [Abstract][Full Text] [Related]
20. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells.
Qiu C; Bu X; Jiang Z
Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]